Screening for cervical cancer: should we test for infection with high-risk HPV?

This publication has 27 references indexed in Scilit:

• Human Papillomavirus Testing for Triage of Women With Cytologic Evidence of Low-Grade Squamous Intraepithelial Lesions: Baseline Data From a Randomized Trial
  JNCI Journal of the National Cancer Institute, 2000
• Correspondence Re: Sherman ME, Tabbara SO, Scott DR, Kurman RJ, Glass AG, Manos MM, et al. “Ascus, Rule Out HSIL”: Cytologic Features, Histologic Correlates, and human Papillomavirus Detection. Mod Pathol 1999;12:335–42.
  Laboratory Investigation, 2000
• Prediction of Recurrent and Residual Cervical Dysplasia by Human Papillomavirus Detection among Patients with Abnormal Cytology
  Gynecologic Oncology, 1999
• Causes of Cervical Cancer in the Philippines: a Case-Control Study
  JNCI Journal of the National Cancer Institute, 1998
• Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens
  American Journal of Obstetrics and Gynecology, 1996
• Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
  JNCI Journal of the National Cancer Institute, 1995
• HPV Prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: The age‐related pattern
  Journal of Medical Virology, 1995
• Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age‐dependent
  International Journal of Cancer, 1993
• Predicting mortality from cervical cancer after negative smear test results.
  BMJ, 1992
• Genital papillomavirus infection after treatment for cervical intraepithelial neoplasia (CIN) III
  Cancer, 1988